Home » Topics » BioWorld Science

BioWorld Science
RSS

AsclepiX obtains funds to advance AXT-107

Nov. 15, 2018

Efflux pumps protect against more than antibiotics

Nov. 15, 2018

How failing hearts try to save themselves

Nov. 15, 2018

How resistant bacteria lock in their gains

Nov. 15, 2018

FDA approves Oralair to treat grass pollen-induced allergic rhinitis in pediatric patients

Nov. 14, 2018

United Neuroscience presents preclinical data on Parkinson's disease vaccine candidate UB-312

Nov. 14, 2018

Calliditas begins phase III study of Nefecon in IgA nephropathy

Nov. 14, 2018

DNAtrix and Valo collaborate to develop armed oncolytic vaccine for cancer therapy

Nov. 14, 2018

Imugene prepares to advance IMU-131 into phase II gastric cancer study

Nov. 14, 2018

PD-1/PD-L1 interaction inhibitors discovered at Nanjing Sanhome Pharmaceutical

Nov. 14, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...